1.
Narrow emission linewidths of positioned InAs quantum dots grown on pre-patterned GaAs(100) substrates
by Skiba-Szymanska, Joanna
Nanotechnology, 2011-02-11, Vol.22 (6), p.065302-065302
2.
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial
by Ellis, Paul, Dr
The Lancet (British edition), 2009, Vol.373 (9676), p.1681-1692
3.
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer reg...
by Coleman, MP, Prof
The Lancet (British edition), 2011, Vol.377 (9760), p.127-138
4.
National Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resection
by Ellis, Ryan J
Annals of surgical oncology, 2019-11-05, Vol.27 (3), p.909-918
5.
RHBDF2 Mutations Are Associated with Tylosis, a Familial Esophageal Cancer Syndrome
by Blaydon, Diana C
American journal of human genetics, 2012-02-10, Vol.90 (2), p.340-346
6.
How Perpetrator Gender Influences Reactions to Premeditated Versus Impulsive Unethical Behavior: A Role Congruity Approach
by Mai, Ke Michael
Journal of business ethics, 2019-01-24, Vol.166 (3), p.489-503
7.
Prescription of secondary prevention medications, lifestyle advice, and referral to rehabilitation among acute coronary syndrome inpatients: results from a large prospective audit...
by Redfern, Julie
Heart (British Cardiac Society), 2014-08, Vol.100 (16), p.1281-1288
8.
9.
The type Ia supernova SNLS-03D3bb from a super-Chandrasekhar-mass white dwarf star
by Andrew Howell, D
Nature, 2006-09-21, Vol.443 (7109), p.308-311
10.
Behavior change interventions: the potential of ontologies for advancing science and practice
by Larsen, Kai R
Journal of behavioral medicine, 2016-08-01, Vol.40 (1), p.6-22
11.
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis
by Sahm, Felix, MD
The lancet oncology, 2017, Vol.18 (5), p.682-694
12.
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2...
by Cameron, David, Prof
The lancet oncology, 2017, Vol.18 (7), p.929-945
13.
Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007–2011
by Ison, Catherine A, Prof
The Lancet infectious diseases, 2013, Vol.13 (9), p.762-768
14.
Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study
by McGill, Fiona
The Lancet infectious diseases, 2018-09, Vol.18 (9), p.992-1003
15.
Glucagon-Like Peptide-1 (GLP-1) Receptors Expressed on Nerve Terminals in the Portal Vein Mediate the Effects of Endogenous GLP-1 on Glucose Tolerance in Rats
by Vahl, Torsten P
Endocrinology (Philadelphia), 2007-10, Vol.148 (10), p.4965-4973
16.
Outcomes, health policy, and managed care: Relationships between patient-reported outcome measures and clinical measures in outpatients with heart failure
by Flynn, Kathryn E., PhD
The American heart journal, 2009, Vol.158 (4), p.S64-S71
17.
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled...
by Coles, Charlotte E
The Lancet (British edition), 2017-09-09, Vol.390 (10099), p.1048-1060
18.
Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial
by Williams, Hywel C, Prof
The Lancet (British edition), 2017, Vol.389 (10079), p.1630-1638
19.
Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial
by Bhatnagar, Aruni
The American heart journal, 2016-09, Vol.179, p.142-150
20.
Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial
by Nisbet-Brown, Eric
The Lancet (British edition), 2003-05-10, Vol.361 (9369), p.1597-1602
